Document is current
Any future updates will be listed below
-
Authors
Montemurro, Paolo
Adams, William P. Jr.
Mallucci, Patrick
De Vita, Roy
Layt, Craig
Calobrace, M. Bradley
Brown, Mitchell H.
Nava, Maurizio B.
Teitelbaum, Steven
del Yerro, José Luis Martín
Bengtson, Bradley
Maxwell, G. Patrick
Hedén, Per https://orcid.org/0000-0002-2123-2308
- License Information
-
More Information
Article History
Received: 30 September 2019
Accepted: 18 December 2019
First Online: 2 January 2020
Compliance with Ethical Standards
:
: Paolo Montemurro is a temporary consultant for Allergan. William P. Adams reports nothing to disclose. Patrick Mallucci is a shareholder in B-Lite (Polytech). Roy De Vita is a temporary consultant for Mentor, Allergan, and Polytech. He is not a shareholder of any Company. Craig Layt is a speaker and consultant for Allergan. Bradley Calobrace is a speaker and on the Medical Advisory Board for Sientra with no financial disclosures. Mitchell Brown reports nothing to disclose. Maurizio B. Nava is a temporary consultant for Allergan and Smith and Nephew. Steven Teitelbaum has had consultancy agreements with Allergan, Mentor, Sientra, and Establishment Labs, and is a shareholder in Establishment Labs. José Luis Martín del Yerro reports nothing to disclose. Bradley Bengtson is on the Innovations Council for LifeCell/Allergan. G. Patrick Maxwell has been a Consultant to Allergan. Per Hedén has had consultancy agreements with Allergan, Mentor, Establishment Labs, G&G Medical and GC Aesthetics, is a shareholder in Polytech and Establishment Labs, and has a Development Contract with Allergan.
: This article does not contain any studies with human participants or animals performed by any of the authors.
: For this type of study, informed consent is not required.
